Strickler H D
Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):523-32.
This nine-laboratory multicenter investigation was designed to assess the sensitivity, specificity, and reproducibility of previously described assays for detection of SV40 DNA with three goals, i.e., (a) to compare methods for testing human tissues, (b) to examine the ability of these methods to detect SV40 in human mesotheliomas, and (c) to uncover assay differences that could explain conflicting findings in some past investigations. Each laboratory received, in a masked fashion, paired replicate DNA samples extracted from 25 fresh frozen mesotheliomas (50 samples) and one from each of 25 normal human lungs. Interspersed were masked positive (titrations of the SV40 genome) and negative control samples. Preliminary studies confirmed the adequacy of the samples for testing high molecular weight double-stranded linear DNA targets. All 15 PCR-based assays detected 5,000 copies or less of the SV40 genome spiked into 2 microg of WI-38 DNA. A high level of specificity and reproducibility was found among the PCR assays performed in most laboratories. However, none of the selected normal human lung tissue or the 25 mesothelioma tumor specimens obtained from archival samples at a single center was reproducibly positive for the presence of SV40 DNA. Further studies are needed to reconcile these results with previous reports of detection of SV40 DNA in tumor specimens.
这项由九个实验室参与的多中心研究旨在评估先前描述的检测SV40 DNA的检测方法的敏感性、特异性和可重复性,有三个目标,即:(a) 比较检测人体组织的方法;(b) 检验这些方法检测人胸膜间皮瘤中SV40的能力;(c) 发现可能解释过去一些研究中相互矛盾结果的检测差异。每个实验室以盲法方式收到从25个新鲜冷冻的间皮瘤中提取的配对重复DNA样本(50个样本)以及25个正常人类肺组织各一个。穿插有盲法阳性(SV40基因组滴定)和阴性对照样本。初步研究证实样本足以检测高分子量双链线性DNA靶标。所有15种基于PCR的检测方法都能检测到掺入2微克WI-38 DNA中的5000个或更少的SV40基因组拷贝。在大多数实验室进行的PCR检测中发现了高度的特异性和可重复性。然而,从单一中心的存档样本中获得的所选正常人类肺组织或25个间皮瘤肿瘤标本中,没有一个能重复检测出SV40 DNA呈阳性。需要进一步研究以将这些结果与先前关于在肿瘤标本中检测到SV40 DNA的报告相协调。